Evidence map›Paper›PMID 34235277›Full record

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case).

A Starshinova, L Guglielmetti, O Rzhepishevska, O Ekaterincheva, Yu Zinchenko, D Kudlay

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Pathogenesis of SARS-CoV-2 andFrontiers in immunology · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

A StarshinovaAlmazov National Medical Research Centre, Saint Petersburg, Russia.
L GuglielmettiAPHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, F-75013 Paris, France.
O RzhepishevskaUmeå University, Umeå, Sweden.
O EkaterinchevaSt. Petersburg Tuberculosis Hospital No. 2, Saint Petersburg, Russia.
Yu ZinchenkoSt. Petersburg Research Institute of Phthisiopulmonology, Russia.
D KudlayI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Federal Almazov North-West Medical Research Centre · RUInstitute of Immunology and Physiology · RUSaint-Petersburg Research Institute of Phthisiopulmonology · RUSorbonne Université · FRUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.

Indexed as

CoronavirusDiagnosisPneumothoraxSARS-CoV-2 InfectionTuberculosis

Identifiers

PMID34235277
PMCPMC8245665
OpenAlexW3173849600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.